Singapore’s Non-oil Domestic Exports (NODX) rebounded, led by electronics and pharmaceuticals, while petrochemicals lagged. Export growth is described as K-shaped, with electronics outperforming and non-electronics facing more strain.
Electronics and semiconductors are supported by demand linked to AI and wider use of AI features in consumer devices. Data points cited include Taiwan’s tech exports to the US peaking on a 3-month moving average year-on-year basis, and South Korea’s semiconductor exports easing in April in nominal terms but staying above US$30bn.
Sector Divergence And Market Implications
Non-electronics exports may soften due to supply shortages in chemicals and higher energy prices, which can reduce external demand. Pharmaceuticals strength is linked to early ordering ahead of announced US tariffs.
The US has announced 100% tariffs on selected patented pharmaceuticals and related ingredients. These are scheduled to take effect on 31 July 2026 for certain large companies and 29 September 2026 for smaller firms.
The article notes it was produced using an AI tool and reviewed by an editor.
Based on the divergence between sectors, a pairs trading strategy appears fitting for the coming weeks. We should consider going long on assets tied to the electronics and semiconductor sector while simultaneously taking short positions on non-electronics, particularly petrochemicals. This approach aims to capitalize on the opposing trends within Singapore’s export market.
Options Positioning For Tech And Cyclicals
The bullish outlook on tech is supported by robust AI-related demand which we believe is not yet peaking. Recent data from the Semiconductor Industry Association for April 2026 showed global chip sales climbing 22% year-over-year, exceeding market expectations. This suggests that call options or bull call spreads on technology-focused ETFs could be profitable as AI applications continue to expand into consumer devices.
Conversely, the non-electronics segment faces significant headwinds from rising energy costs and supply disruptions. With Brent crude prices holding steady around $95 a barrel in May 2026, margins for chemical and petrochemical producers are being compressed, a situation reminiscent of the supply chain challenges we saw in 2025. This makes put options on industrial or materials sector indices an attractive hedge against this expected weakness.
A separate, time-sensitive opportunity exists in the pharmaceutical sector due to impending US tariffs. We are observing front-loading of exports, with logistics firms reporting a 15% sequential jump in pharmaceutical air freight to the US in April 2026. A long position on relevant pharmaceutical stocks could capture this short-term surge, but we must be prepared to exit before the July 31st tariff implementation date when demand is likely to sharply contract.
